A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination

Authors:

Abstract
No abstract available

This publication has 37 references indexed in Scilit: